Cassidy Blundell
Director/Miembro de la Junta en Arase Therapeutics, Inc. .
Perfil
Cassidy Blundell is currently working as a Principal at BioInnovation Management LLC and is also a Board Member at Arase Therapeutics, Inc. She holds a doctorate degree from the University of Pennsylvania, which she received in 2018, and a graduate degree from Boston University, which she received in 2012.
Cargos activos de Cassidy Blundell
Empresas | Cargo | Inicio |
---|---|---|
Arase Therapeutics, Inc.
Arase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arase Therapeutics, Inc. is a science-focused oncology company located in Cambridge, MA. The company is developing first-in-class therapeutics targeting adp-ribose hydrolases, novel targets that function therapeutically. The company's leadership includes scientists and founders Paul Chang, Ph.D., W. Lee Kraus, Ph.D., and Michael Taylor, Ph.D. The company's mission is supported by Biocapital, a founding investor, and the board is led by Paul Chang, Ph.D., who serves as the President, CEO/CSO, and lead founder. Cassidy Blundell, Ph.D., a principal at Mission Biocapital, and W. Lee Kraus, Ph.D., a scientific founder, also serve on the board. | Director/Miembro de la Junta | - |
BioInnovation Management LLC
BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Inversor de Capital Privado | 01/09/2021 |
Formación de Cassidy Blundell.
University of Pennsylvania | Doctorate Degree |
Boston University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Arase Therapeutics, Inc.
Arase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arase Therapeutics, Inc. is a science-focused oncology company located in Cambridge, MA. The company is developing first-in-class therapeutics targeting adp-ribose hydrolases, novel targets that function therapeutically. The company's leadership includes scientists and founders Paul Chang, Ph.D., W. Lee Kraus, Ph.D., and Michael Taylor, Ph.D. The company's mission is supported by Biocapital, a founding investor, and the board is led by Paul Chang, Ph.D., who serves as the President, CEO/CSO, and lead founder. Cassidy Blundell, Ph.D., a principal at Mission Biocapital, and W. Lee Kraus, Ph.D., a scientific founder, also serve on the board. | Health Technology |
BioInnovation Management LLC
BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Bolsa de valores
- Insiders
- Cassidy Blundell